Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older

The Korean National Health Insurance revised its reimbursement criteria to expand coverage for anti-osteoporotic drug treatments in 2011 (expanding diagnostic criteria and the coverage period for anti-osteoporotic therapy) and 2015 (including osteoporotic fracture patients regardless of bone mineral...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2020-12, Vol.15 (12), p.e0244759-e0244759
Hauptverfasser:	Koo, Ja Seo, Moon, Seong Hwan, Lee, Hankil, Park, Sohee, Yu, Yun Mi, Kang, Hye-Young
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biology and Life Sciences Biomedical materials Bisphosphonates Bone Density Bone Density Conservation Agents - economics Bone Density Conservation Agents - therapeutic use Bone mineral density Bone surgery Care and treatment Demographic aspects Diagnostic systems Drug therapy Drugs Female Fractures Health insurance Humans Influence Insurance Insurance, Health, Reimbursement Laws, regulations and rules Medicine and Health Sciences Menopause Middle Aged National health insurance National Health Programs Older people Osteoporosis Osteoporosis - drug therapy Osteoporosis - economics Osteoporotic Fractures - drug therapy Osteoporotic Fractures - economics Patients People and Places Pharmaceutical sciences Pharmacy Physical Sciences Policy Population Population studies Post-menopause Prospective payment systems (Medical care) Public health Regression analysis Republic of Korea Research and Analysis Methods Revisions Social Sciences Statistical analysis Time series Trends Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!